• Bone-safe glucocorticoid dose ‘hard to find' in rheumatic, musculoskeletal diseases

    7 days ago - By Healio

    PHILADELPHIA - A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.
    “If you give 5 mg of prednisolone in rheumatoid arthritis, you will benefit disease activity,” Giovanni Adami, MD, of the rheumatology unit at the University of Verona, in Italy, said in his presentation. “But what is the tradeoff?”
    Adami and colleagues aimed to assess patients with RA, systemic lupus erythematosus, psoriatic arthritis, systemic
    Read more ...